Cargando…
Engaging novel cell types, protein targets and efficacy biomarkers in the treatment of diabetic nephropathy
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124518/ https://www.ncbi.nlm.nih.gov/pubmed/25147524 http://dx.doi.org/10.3389/fphar.2014.00185 |
| _version_ | 1782329632159170560 |
|---|---|
| author | Fryer, Ryan M. Boustany-Kari, Carine M. MacDonnell, Scott M. |
| author_facet | Fryer, Ryan M. Boustany-Kari, Carine M. MacDonnell, Scott M. |
| author_sort | Fryer, Ryan M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4124518 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-41245182014-08-21 Engaging novel cell types, protein targets and efficacy biomarkers in the treatment of diabetic nephropathy Fryer, Ryan M. Boustany-Kari, Carine M. MacDonnell, Scott M. Front Pharmacol Pharmacology Frontiers Media S.A. 2014-08-07 /pmc/articles/PMC4124518/ /pubmed/25147524 http://dx.doi.org/10.3389/fphar.2014.00185 Text en Copyright © 2014 Fryer, Boustany-Kari and MacDonnell. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Pharmacology Fryer, Ryan M. Boustany-Kari, Carine M. MacDonnell, Scott M. Engaging novel cell types, protein targets and efficacy biomarkers in the treatment of diabetic nephropathy |
| title | Engaging novel cell types, protein targets and efficacy biomarkers in the treatment of diabetic nephropathy |
| title_full | Engaging novel cell types, protein targets and efficacy biomarkers in the treatment of diabetic nephropathy |
| title_fullStr | Engaging novel cell types, protein targets and efficacy biomarkers in the treatment of diabetic nephropathy |
| title_full_unstemmed | Engaging novel cell types, protein targets and efficacy biomarkers in the treatment of diabetic nephropathy |
| title_short | Engaging novel cell types, protein targets and efficacy biomarkers in the treatment of diabetic nephropathy |
| title_sort | engaging novel cell types, protein targets and efficacy biomarkers in the treatment of diabetic nephropathy |
| topic | Pharmacology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124518/ https://www.ncbi.nlm.nih.gov/pubmed/25147524 http://dx.doi.org/10.3389/fphar.2014.00185 |
| work_keys_str_mv | AT fryerryanm engagingnovelcelltypesproteintargetsandefficacybiomarkersinthetreatmentofdiabeticnephropathy AT boustanykaricarinem engagingnovelcelltypesproteintargetsandefficacybiomarkersinthetreatmentofdiabeticnephropathy AT macdonnellscottm engagingnovelcelltypesproteintargetsandefficacybiomarkersinthetreatmentofdiabeticnephropathy |